Larvol Delta - Phase-1b-Study-of-AEVI007-in-Subjects-With-Relapsed-or-Refractory-Multiple-Myeloma

camoteskimab (AVTX-007) - Apollo Therap

http://clinicaltrials.gov/ct2/show/NCT04671251

Feb 29, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next